Salivary Gland Cancer
📧 Sign up to get email alerts when something new happens for Salivary Gland Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer [Phase 3]
Phase 3 clinical trial comparing I-125 brachytherapy to intensity-modulated radiation therapy for inoperable salivary gland cancer; the curr…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors [Phase 2]
A randomized Phase II trial compared adjuvant concurrent radiation and chemotherapy versus radiation alone after surgical resection of high-…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating OPB-111001 in multiple advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab [Phase 2]
This Phase II randomized trial assessed cetuximab with sorafenib versus cetuximab alone in metastatic head and neck squamous cell carcinomas…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating sunitinib for recurrent and/or metastatic adenoid cystic carcinoma of the sa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the Akt inhibitor MK2206 in patients with progressive, recurrent, or metastatic adenoid cystic carcinoma o…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial update for cediranib maleate in patients with recurrent or metastatic head and neck squamous cell carcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors [Phase 2]
A Phase 2 trial evaluating dasatinib for recurrent or metastatic malignant salivary gland tumors has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck [Phase 1]
Phase 1 trial evaluating the combination of the TLR8 agonist VTX-2337 with cetuximab for locally advanced, recurrent, or metastatic squamous…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the combination of erlotinib and docetaxel in patients with locally advanced, metastatic, or recur…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This document provides an update on a Phase 2 trial of sorafenib for patients with recurrent or metastatic head and neck cancer and indicate…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer [Phase 2]
A Phase 2 trial evaluating trastuzumab in metastatic or recurrent salivary gland cancers has been terminated. The study included histologies…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck [Phase 2]
This Phase 2 trial update examines bortezomib followed by doxorubicin at progression in patients with locally advanced, recurrent, or metast…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.